Health Payer Intelligence January 22, 2021
Kelsey Waddill

Payers will hone their telehealth and gene therapy strategies in 2021 and will also refine their forecasting capabilities.

In 2021, payers will expand upon lessons learned about telehealth and gene therapy in 2020 as they implement their strategies in the new year.

Listen to the full podcast to hear more details. And don’t forget to subscribe on iTunes, Spotify, or Google Podcasts.

Now that telehealth utilization has become more widespread, payers will work toward integrating virtual care and telehealth.

Over the course of the pandemic, payers had the opportunity to use telehealth and virtual care in a variety of contexts. As a result, the healthcare system has more data on what uses are best suited to telehealth.

For example, the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Digital Health, Health IT, Insurance, Patient / Consumer, Payer, Pharma / Biotech, Precision Medicine, Provider, Technology, Telehealth
Teladoc expands virtual sitter capabilities
AHA, others urge Congress to act on alternative payment models, avoid physician payment cut
Are telehealth visits for pediatric primary care associated with higher rates of health care utilization?
Hospital recovery at risk if Congress doesn’t extend telehealth, Fitch Ratings says
End of home health, telehealth coverage threatens hospitals' recovery: Fitch

Share This Article